The 4th Immuno-Oncology Profiling Congress will bring together high level, global speakers from big pharma, biotech, academia and industry to discuss the clinical and commercial aspects that are impacting the reality of incorporating the precision medicine approach into immuno-oncology. Explore the latest methods and technologies that allow better understanding of the immune system, and improve therapeutic design and treatment strategies in cancer immunotherapy.
Hear clinical trial updates and discuss the importance of a collaborative approach to advance cancer treatment. Alongside, joining in discussions on how immune profiling & bioinformatics techniques can be integrated with break through immunotherapy approaches like
Antibody Therapies, Adoptive T-Cell Therapies, NK Cell Therapies, personalized Cancer Vaccines, Oncolytic Virus’
We bring you 3 days packed full of top level science, data and case studies, workshops, roundtables and networking opportunities. Co-located with the 20th World Vaccine Congress, the event connects infectious disease immunologists with cancer experts to help accelerate research & development and collaboration. With 175+ speakers, 600+ attendees and hundreds of companies in attendance, this is not an event to be missed.
IMMUNOTHERAPY APPROACHES & COMBINATION STRATEGIES
IMMUNE PROFILING IN CANCER
BIG DATA IN ONCOLOGY
BIOMARKERS & PATIENT SELECTION
BRIDGING INFECTIOUS DISEASE & CANCER
The Immuno-Oncology Profiling Congress offers outstanding opportunities for service and solution providers, from senior sponsorship to a range of exhibition booths. If you are looking to gain access to key vaccine decision makers then this is your best ROI in 2019.
Very good organization, interesting mix of talks, good balance between panels and parallel tracks
Head R&D, Marburg GSK Vaccines